Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic

Published:2023-10-05 Issue:4 Volume:17 Page:267-272
ISSN:1802-4475
Container-title:Onkologie
language:
Short-container-title:Onkologie

Author:

Michalka Jozef,Král Zdeněk,Marková Jana,Gahérová Ľubica,Maco Mária,Procházka Vít,Janíková Andrea,Kořen Jan,Sýkorová Alice,Štěpánková Pavla,Steinerová Kateřina,Mohammad Lekaa,Ďuraš Juraj,Velacková Barbora,Doležal Tomáš,Benešová Kateřina,Lukášová Marie,Móciková Heidi

Publisher

Solen s.r.o.

Subject

Cancer Research,Oncology

Link

http://www.onkologiecs.cz/doi/10.36290/xon.2023.051.pdf

Reference14 articles.

1. Classical Hodgkin lymphoma

2. Autologous Stem Cell Transplantation in Hodgkin Lymphoma—Latest Advances in the Era of Novel Therapies

3. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

4. Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse;Moskowitz CH;Blood,2018

5. Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP